
    
      To register a large number of patients with the diagnosis of a BCR-ABL 1- negative myeloid
      neoplasm (according to WHO 2008 classification) in participating centers

      To store samples from all patients (e.g. bone marrow aspirate, peripheral blood, plasma, and
      buccal swap, skin biopsy samples in exceptional cases)

      To perform morphologic and genetic analyses

      To assess clinical characteristics and outcome data using a defined catalogue containing
      clinically relevant variables

      To assess biological disease features and correlate with clinical outcome data (prognostic
      and predictive markers)

      To assess quality of life
    
  